RE: Still positive15 Sep 2022 12:19
Mr India - you are showing yourself up as an absolute fool. Your attitude yoyo in a matter of weeks, days, even hours
Vlad and the team have made great progress over the last 12mths - following some challenges, partly due to pandemic
THIS IS BIOTECH - things don't change in weeks. All sensible investors here understand the timelines and the potential.
Its been a tough three years to get funding and this hurt Hemo. However, that is all history now, they are funded to take CarT into the clinic and make further progress on CBR and CDX Antibody.
Whilst not without risk, the current SP represents a genuine once in a lifetime investment opportunity. High risk, High Reward - with initial funding completed, it really is all about the science in the next 6mths